BCM
Bayesian Capital Management’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-213,900
| Closed | -$364K | – | 905 |
|
|
2024
Q3 | $364K | Buy |
+213,900
| New | +$364K | 0.04% | 434 |
|
|
2023
Q3 | – | Sell |
-10,836
| Closed | -$144K | – | 909 |
|
|
2023
Q2 | $144K | Buy |
+10,836
| New | +$144K | 0.02% | 670 |
|
|
2019
Q2 | – | Sell |
-16,900
| Closed | -$122K | – | 647 |
|
|
2019
Q1 | $122K | Sell |
16,900
-16,994
| -50% | -$123K | 0.02% | 501 |
|
|
2018
Q4 | $251K | Buy |
+33,894
| New | +$251K | 0.05% | 461 |
|
|
2017
Q4 | – | Sell |
-10,200
| Closed | -$54K | – | 677 |
|
|
2017
Q3 | $54K | Buy |
+10,200
| New | +$54K | 0.01% | 458 |
|
|
2016
Q4 | – | Sell |
-31,510
| Closed | -$282K | – | 675 |
|
|
2016
Q3 | $282K | Buy |
31,510
+14,710
| +88% | +$132K | 0.19% | 209 |
|
|
2016
Q2 | $118K | Buy |
+16,800
| New | +$118K | 0.07% | 356 |
|